Specifically, this investigation reveals that the ubiquitin-coupled enzyme E2S (UBE2S) is markedly upregulated in breast cancer and exerts a modulatory effect on the phosphorylation of FAK at Tyr397, thereby impeding integrin signaling. Here, UBE2S is linked to breast cancer.